EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER
    10.
    发明申请
    EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER 审中-公开
    用于肝脏的抗纤维化作用的机制

    公开(公告)号:US20130137649A1

    公开(公告)日:2013-05-30

    申请号:US13691604

    申请日:2012-11-30

    Abstract: This invention demonstrates the therapeutic efficacy of Yang-Gan-Wan (YGW) and its active components, especially in the formulation provided by Sheng-Pu Pharmaceutials, Inc., for treating and preventing liver fibrosis. This invention further demonstrates MeCP2 is an important therapeutic target for YGW and its active ingredients' action against liver fibrosis and cirrhosis.

    Abstract translation: 本发明证明了杨甘万(YGW)及其活性成分的治疗效果,特别是在盛普药业有限公司提供的治疗和预防肝纤维化方面的疗效。 本发明进一步表明MeCP2是YGW及其活性成分对肝纤维化和肝硬化的作用的重要治疗靶标。

Patent Agency Ranking